Cargando…
The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
Pulmonary vascular resistance (PVR) is traditionally used to describe pulmonary hemodynamic characteristics. However, it does not take into account pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and Ca is known as RC time. Previous studies assert that the PVR-Ca relationship...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425968/ https://www.ncbi.nlm.nih.gov/pubmed/25902784 http://dx.doi.org/10.14814/phy2.12363 |
_version_ | 1782370554194427904 |
---|---|
author | Hadinnapola, Charaka Li, Qiuju Su, Li Pepke-Zaba, Joanna Toshner, Mark |
author_facet | Hadinnapola, Charaka Li, Qiuju Su, Li Pepke-Zaba, Joanna Toshner, Mark |
author_sort | Hadinnapola, Charaka |
collection | PubMed |
description | Pulmonary vascular resistance (PVR) is traditionally used to describe pulmonary hemodynamic characteristics. However, it does not take into account pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and Ca is known as RC time. Previous studies assert that the PVR-Ca relationship is fixed and RC time is constant between health and disease states. We hypothesized that RC time was not constant in health and pulmonary vascular disease. Right heart catheterizations performed in Papworth Hospital over a 6 year period were analyzed. Subjects were divided into those with normal pulmonary hemodynamics (NPH group; n = 156) and pulmonary arterial hypertension (PAH group; n = 717). RC time and the right ventricle (RV) oscillatory power fraction were calculated. RC time for the NPH group (0.47 ± 0.13 sec) is significantly lower than the PAH group (0.56 ± 0.16 sec; P < 0.0001). The RV oscillatory power fraction is lower in the NPH group (P < 0.0001). RC time correlates inversely with the RV oscillatory power fraction in each group. We conclude, there is an inverse relationship between PVR and Ca, however, this relationship is not always fixed. Consequently, RC time is significantly lower in health compared to disease with elevated pulmonary artery pressures. PAH leads to a decrease in cardiac efficiency. |
format | Online Article Text |
id | pubmed-4425968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44259682015-05-14 The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease Hadinnapola, Charaka Li, Qiuju Su, Li Pepke-Zaba, Joanna Toshner, Mark Physiol Rep Original Research Pulmonary vascular resistance (PVR) is traditionally used to describe pulmonary hemodynamic characteristics. However, it does not take into account pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and Ca is known as RC time. Previous studies assert that the PVR-Ca relationship is fixed and RC time is constant between health and disease states. We hypothesized that RC time was not constant in health and pulmonary vascular disease. Right heart catheterizations performed in Papworth Hospital over a 6 year period were analyzed. Subjects were divided into those with normal pulmonary hemodynamics (NPH group; n = 156) and pulmonary arterial hypertension (PAH group; n = 717). RC time and the right ventricle (RV) oscillatory power fraction were calculated. RC time for the NPH group (0.47 ± 0.13 sec) is significantly lower than the PAH group (0.56 ± 0.16 sec; P < 0.0001). The RV oscillatory power fraction is lower in the NPH group (P < 0.0001). RC time correlates inversely with the RV oscillatory power fraction in each group. We conclude, there is an inverse relationship between PVR and Ca, however, this relationship is not always fixed. Consequently, RC time is significantly lower in health compared to disease with elevated pulmonary artery pressures. PAH leads to a decrease in cardiac efficiency. BlackWell Publishing Ltd 2015-04-22 /pmc/articles/PMC4425968/ /pubmed/25902784 http://dx.doi.org/10.14814/phy2.12363 Text en © 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Hadinnapola, Charaka Li, Qiuju Su, Li Pepke-Zaba, Joanna Toshner, Mark The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease |
title | The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease |
title_full | The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease |
title_fullStr | The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease |
title_full_unstemmed | The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease |
title_short | The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease |
title_sort | resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425968/ https://www.ncbi.nlm.nih.gov/pubmed/25902784 http://dx.doi.org/10.14814/phy2.12363 |
work_keys_str_mv | AT hadinnapolacharaka theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT liqiuju theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT suli theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT pepkezabajoanna theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT toshnermark theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT hadinnapolacharaka resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT liqiuju resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT suli resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT pepkezabajoanna resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease AT toshnermark resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease |